Trade name: Cefepime (IM)

MNN: Cefepime

ATC code: [J01DE01]

Description:

Intramuscular injections are the main route of administration of antibiotics in general clinical practice. In order to optimize drug product provision of of hospitals and out-patient departments, safety of parenteral medicinal products usage and to increase compliance of antibiotic therapy, Kraspharma OJSC produces Cefepime as powder for solution for intramuscular injection. It is supplied in packs of 1 vial containing powder for injection and 1 ampoule containing a 1% lidocaine hydrochloride solution as a solvent. This formulation is intended for empiric and etiotropic therapy of different types of moderate to severe community-acquired and nosocomial infections. It can be used empirically, without waiting for further clinical or microbiological evidence of infection.

SmPC PIL
Strength Presentation Quantity in package Solvent Quantity of solvent

0.5 g

vial

1

-

-

0.5 g

vial

10

-

-

0.5 g

vial

50

-

-

0.5 g

vial

1-50

-

-

0.5 g

vial

1

Water for injections, amp. of 5 ml

1

0.5 g

vial

5

Water for injections, amp. of 5 ml

5

0.5 g

vial

1

1% Lidocaine solution, amp. of 3.5 ml

1

0.5 g

vial

5

1% Lidocaine solution, amp. of 3.5 ml

5

1.0 g

vial

1

-

-

1.0 g

vial

10

-

-

1.0 g

vial

50

-

-

1.0 g

vial

1-50

-

-

1.0 g

vial

1

Water for injections, amp. of 5 ml

1

1.0 g

vial

5

Water for injections, amp. of 5 ml

5

1.0 g

vial

1

1% Lidocaine solution, amp. of 3.5 ml

1

1.0 g

vial

5

1% Lidocaine solution, amp. of 3.5 ml

5